MedTrace Logo

Psychiatric and Cognitive Manifestations of Parkinson's Disease

NCT00360633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2019-05-10

No results posted yet for this study

Summary

Parkinson's Disease (PD) is often thought of as affecting movement only. In fact, most patients also experience psychiatric and cognitive symptoms, sometimes from the disease itself, and sometimes as a side-effect of PD medications. The goals of this study are to evaluate the causes, effects, and clinical correlates of psychiatric and cognitive symptoms in PD.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Melissa J Nirenberg, MD, PhD · NYU School of Medicine

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2019-03-28
Completion
2019-03-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00360633 on ClinicalTrials.gov